133 related articles for article (PubMed ID: 2787294)
1. Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or beta.
Belardelli F; Proietti E; Ciolli V; Sestili P; Carpinelli G; Di Vito M; Ferretti A; Woodrow D; Boraschi D; Podo F
Int J Cancer; 1989 Jul; 44(1):116-23. PubMed ID: 2787294
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha induces early morphologic and metabolic alterations in Friend leukemia cell tumors and fibrosarcomas in mice.
Proietti E; Belardelli F; Carpinelli G; Di Vito M; Woodrow D; Moss J; Sestili P; Fiers W; Gresser I; Podo F
Int J Cancer; 1988 Oct; 42(4):582-91. PubMed ID: 3170030
[TBL] [Abstract][Full Text] [Related]
3. Nuclear magnetic resonance analysis of tumor necrosis factor-induced alterations of phospholipid metabolites and pH in Friend leukemia cell tumors and fibrosarcomas in mice.
Podo F; Carpinelli G; Di Vito M; Giannini M; Proietti E; Fiers W; Gresser I; Belardelli F
Cancer Res; 1987 Dec; 47(24 Pt 1):6481-9. PubMed ID: 3677088
[TBL] [Abstract][Full Text] [Related]
4. 31P-nuclear magnetic resonance analysis of interferon-induced alterations of phospholipid metabolites in interferon-sensitive and interferon-resistant Friend leukemia cell tumors in mice.
Proietti E; Carpinelli G; Di Vito M; Belardelli F; Gresser I; Podo F
Cancer Res; 1986 Jun; 46(6):2849-57. PubMed ID: 2421886
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor effects of interleukin-2 and interleukin-1 in mice transplanted with different syngeneic tumors.
Belardelli F; Ciolli V; Testa U; Montesoro E; Bulgarini D; Proietti E; Borghi P; Sestili P; Locardi C; Peschle C
Int J Cancer; 1989 Dec; 44(6):1108-16. PubMed ID: 2606579
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant Friend leukemia cells. V. Comparisons with the action of tumor necrosis factor.
Gresser I; Belardelli F; Tavernier J; Fiers W; Podo F; Federico M; Carpinelli G; Duvillard P; Prade M; Maury C
Int J Cancer; 1986 Nov; 38(5):771-8. PubMed ID: 3464571
[TBL] [Abstract][Full Text] [Related]
7. Combined interleukin 1/interleukin 2 therapy of mice injected with highly metastatic Friend leukemia cells: host antitumor mechanisms and marked effects on established metastases.
Ciolli V; Gabriele L; Sestili P; Varano F; Proietti E; Gresser I; Testa U; Montesoro E; Bulgarini D; Mariani G
J Exp Med; 1991 Feb; 173(2):313-22. PubMed ID: 1671080
[TBL] [Abstract][Full Text] [Related]
8. Interaction of IFN alpha/beta with host cells essential to the early inhibition of Friend erythroleukemia visceral metastases in mice.
Gresser I; Kaido T; Maury C; Woodrow D; Moss J; Belardelli F
Int J Cancer; 1994 May; 57(4):604-11. PubMed ID: 8181864
[TBL] [Abstract][Full Text] [Related]
9. Alterations of lipid composition in Friend leukemia cell tumors in mice treated with tumor necrosis factor-alpha.
Bravo E; Carpinelli G; Proietti E; Belardelli F; Cantafora A; Podo F
FEBS Lett; 1990 Jan; 260(2):220-4. PubMed ID: 2298300
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mouse alpha/beta-interferon of the multiplication of alpha/beta-interferon-resistant Friend erythroleukemia cells cocultured with mouse hepatocytes.
Yasui H; Proietti E; Vignaux F; Eid P; Gresser I
Cancer Res; 1990 Jun; 50(12):3533-9. PubMed ID: 2140290
[TBL] [Abstract][Full Text] [Related]
11. Synergistic anti-tumor effects of combined IL-1/IFN-alpha/beta therapy in mice injected with metastatic Friend erythroleukemia cells.
Belardelli F; Gabriele L; Proietti E; Sestili P; Peretti M; Rozera C; Gresser I
Int J Cancer; 1991 Sep; 49(2):274-8. PubMed ID: 1879971
[TBL] [Abstract][Full Text] [Related]
12. Sensitized T lymphocytes render DBA/2 beige mice responsive to IFN alpha/beta therapy of Friend erythroleukemia visceral metastases.
Kaido T; Gresser I; Maury C; Maunoury MT; Vignaux F; Belardelli F
Int J Cancer; 1993 May; 54(3):475-81. PubMed ID: 8509222
[TBL] [Abstract][Full Text] [Related]
13. Antibody to mouse interferon alpha/beta abrogates resistance to the multiplication of Friend erythroleukemia cells in the livers of allogeneic mice.
Gresser I; Maury C; Vignaux F; Haller O; Belardelli F; Tovey MG
J Exp Med; 1988 Oct; 168(4):1271-91. PubMed ID: 3171480
[TBL] [Abstract][Full Text] [Related]
14. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.
Dvorak HF; Gresser I
J Natl Cancer Inst; 1989 Apr; 81(7):497-502. PubMed ID: 2921774
[TBL] [Abstract][Full Text] [Related]
15. Modulations of glycerophosphorylcholine and phosphorylcholine in Friend erythroleukemia cells upon in vitro-induced erythroid differentiation: a 31P NMR study.
Carpinelli G; Podo F; Di Vito M; Proietti E; Gessani S; Belardelli F
FEBS Lett; 1984 Oct; 176(1):88-92. PubMed ID: 6593228
[TBL] [Abstract][Full Text] [Related]
16. Acute hemorrhagic necrosis of tumors induced by interleukin-1 alpha: effects independent of tumor necrosis factor.
Johnson CS; Chang MJ; Braunschweiger PG; Furmanski P
J Natl Cancer Inst; 1991 Jun; 83(12):842-8. PubMed ID: 2061944
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of recombinant human interleukin 1 alpha in RIF-1 and Panc02 solid tumors.
Braunschweiger PG; Johnson CS; Kumar N; Ord V; Furmanski P
Cancer Res; 1988 Nov; 48(21):6011-6. PubMed ID: 3262418
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
[TBL] [Abstract][Full Text] [Related]
20. Biologic and biochemical differences between in vitro and in vivo passaged Friend erythroleukemia cells. I. Tumorigenicity and capacity to metastasize.
Belardelli F; Ferrantini M; Maury C; Santurbano L; Gresser I
Int J Cancer; 1984 Sep; 34(3):389-95. PubMed ID: 6207117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
